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The first cases of dementia with cortical Lewy bodies were reported by Okazaki et al. 2 . Since then about 300 further cases have been described. Lewy body dementia (LBD) is common in post-mortem series, the mean frequency in six post-mortem series being 12.5%. In vivo LBD has been found in 23% of patients with dementia attending a day-hospital3 and in 12% of patients presenting to psychogeriatric service4.
Although it has been designated a disease entity, a variety of Alzheimer's disease (AD) and a spectrum disorder5, the nosological status of LBD is not yet resolved. There are two main reasons for this. One is the heterogeneity of the pathological findings; the majority of cases have Lewy bodies in the brain stem and cerebral cortex (a few cases have been reported with cortical Lewy bodies only Kosaka et al.6) together with a variable degree of Alzheimer's histology, senile plaques and neurofibrillary tangles. The second is the heterogeneity of the clinical features, some cases resembling AD other PD and others vascular dementia (VaD)7.
CLINICAL FEATURES
The clinical features of LBD are dementia, Parkinsonism and usually prominent neuropsychiatric symptoms.
Dementia
Dementia fulfilling standard operational criteria for the syndrome (Diagnostic and Statistical Manual of Mental Disorders, International Classification of Diseases) occurs in the majority of cases. Some have found that the cognitive deficits are milder in severity at onset8'9, whereas others report no difference. There is some data to suggest that LBD patients have more prominent disorders of attention, visuospacial processing and visual memory than cases of AD9.
The most striking abnormality in the cognitive changes in LBD is that they fluctuate dramatically over time.
Patients who in the morning were interacting with other residents may be observed in the afternoon of the same day to be mumbling incoherently, with an equally rapid reversion to the morning's level of performance by the same evening. These rapid fluctuations are hard to quantify; visual analogue scales can be useful as can the clock drawing testl 1. Superimposed on this background of fluctuating cognitive performance are episodes resembling delirium for which no cause is ever found8'12. 
Course of the illness
The mean duration of illness is 5-7 years17. Many cases continue to fluctuate in cognitive performance until late in the course when they may resemble the late states of AD. There are only hints in the literature of the challenging and difficult clinical problems caused by LBD. The psychotic features, when they occur are so florid and troublesome to the sufferer that neuroleptics may be prescribed. In this case there is a high probability that the patient will become seriously unwell-the neuroleptic sensitivity syndrome. This condition may be precipitated by both conventional and novel neuroleptics even in very small J R Soc Med 1997;90(Suppl. 32): [14] [15] Department of Psychiatry, Wthington Hospital, West Didsbury, Manchester M20 8LR, England doses and is associated with a high mortality. In those who survive, both the Parkinsonian features and the psychotic features (paradoxically) are very severe, and require intensive nursing and medical care, 24h a day often for many weeks.
DIAGNOSIS
Two operational clinical criteria have been devised18-20 and have been validated against post-mortem findings. New consensus criteria for both the clinical and pathological diagnosis will shortly be available as a result of the International Workshop on LBD held in Newcastle in November 199521. A simple bedside test, the clock drawing test, may be helpful in distinguishing between LBD, AD and PD. Patients are asked first to draw a clockface and to insert the hands in the correct position for a specific time, then they are asked to copy a standard clockface. Lewy body patients, are less likely to improve on the 'copy' part of the clock drawing test (CDT) than either AD or PD patients.
Ghanalingham et al.22 report a sensitivity of 25% and specificity of 98% where the 'draw' score is greater than the 'copy' score on the CDT, and a sensitivity of 88% and specificity of 87% where the 'draw' score is greater or equal to the 'copy' score. It is not yet established whether this is an order effect and cases of VaD also fail to improve on the 'copy' part of the CDT.
The electroencephalogram is also helpful in diagnosis, in LBD abnormalities (bursts of slow wave activity theta, delta in temporal areas) are seen early in the course of the illness whereas in AD the electroencephalograph is often normal in the early stages7'23. MANAGEMENT The motor symptoms in some cases may be helped by low doses of levadopa. Psychiatric symptoms may respond to chlormethiazole, sodium valproate (up to 300 mg/day) or to risperidone29. Some cases may be managed by practical help and counselling rather than pharmacotherapy. CONCLUSION LBD is probably common, presents great challenges to physicians caring for sufferers and to the sufferers themselves and their families. The study of LBD has potential benefits for the understanding of other neurodegenerative disorders such as AD and PD.
